Michael Pawlak's Biography

Michael Pawlak, Head, University of Tuebingen

Dr. Michael Pawlak joined the NMI in 2005 and is heading the Department of Biochemistry and Protein Profiling. In a multidisciplinary environment, scientists develop advanced assay systems and applications for industrial partners. Dr. Pawlak's research is focused on the application of microarrays for proteomic and cancer research, including the study of mechanisms of disease and drug action, and the identification of biomarkers for use in personalized medicine. He is offering protein profiling services to pharmaceutical industry and clinical research using Reverse Phase Protein Arrays for the analysis of protein signaling networks. Before Dr. Pawlak was at Novartis Pharma AG and co-founder of Zeptosens AG, and was pioneering sensitive planar waveguide technology for use with Reverse Phase Protein Arrays.